Immunocore Holdings Plc Adr (IMCR)

Jan 13, 2025

Wall Street Analysts Believe Immunocore (IMCR) Could Rally 113.13%: Here's is How to Trade - Yahoo Finance

Jan 13, 2025

Jan 06, 2025

Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 06, 2025

Dec 27, 2024

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why - Zacks Investment Research

Dec 27, 2024

Dec 26, 2024

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025 - Yahoo Finance

Dec 26, 2024

Dec 24, 2024

BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term - Yahoo Finance

Dec 23, 2024

Dec 13, 2024

Disappointing data leads to Immunocore stock downgrade by Morgan Stanley - Investing.com South Africa

Dec 13, 2024

Dec 13, 2024

Immunocore stock hits 52-week low at $29.23 amid market challenges - Investing.com

Dec 13, 2024

Dec 13, 2024

Immunocore's SWOT analysis: TCR pioneer's stock faces pivotal year - Investing.com

Dec 13, 2024

Dec 12, 2024

All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study - Yahoo Finance

Dec 12, 2024

Dec 12, 2024

New Strong Buy Stocks for December 12th - Yahoo Finance

Dec 12, 2024

Dec 04, 2024

RZLT Stock Rises On FDA's Orphan Designation For Rare Disease Drug - Barchart

Dec 04, 2024

Dec 03, 2024

SNTI Stock Skyrockets On Initial Data From Phase I Cancer Study - Barchart

Dec 03, 2024

Dec 02, 2024

Altimmune Stock Up More Than 25% In A Month: Here's Why - Barchart

Dec 02, 2024

Nov 29, 2024

Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect? - MSN

Nov 29, 2024

Nov 29, 2024

Mirum Shares Surge More Than 90% in 6 Months: Here's Why - Yahoo Finance

Nov 29, 2024

Nov 26, 2024

Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know - MSN

Nov 26, 2024

Nov 26, 2024

New Strong Buy Stocks for November 26th - Yahoo Finance

Nov 26, 2024

Nov 20, 2024

Stack Capital Group announces normal course issuer bid - MSN

Nov 20, 2024

Nov 19, 2024

FATE Presents Encourgaing Data From Lupus Study, Stock Gains - Barchart

Nov 19, 2024

Nov 19, 2024

Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study - Nasdaq

Nov 19, 2024

Nov 19, 2024

What will it take for small caps to finally outperform large caps on earnings, performance? - MSN

Nov 19, 2024

Nov 17, 2024

Immunocore (IMCR) Upgraded to Buy: Here's Why - MSN

Nov 17, 2024

Nov 13, 2024

Immunocore's SWOT analysis: biotech stock faces pivotal moment amid PRAME data - Investing.com India

Nov 13, 2024

Nov 13, 2024

FATE Q3 Earnings Beat On Higher Revenues, Pipeline In Focus - Barchart

Nov 13, 2024

Nov 13, 2024

SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark - Barchart

Nov 13, 2024

Nov 12, 2024

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised - Barchart

Nov 12, 2024

Nov 11, 2024

Mizuho downgrades Immunocore stock to Neutral, slashes PT to $38 from $72 - Investing.com

Nov 11, 2024

Nov 11, 2024

Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline In Focus - Barchart

Nov 11, 2024

Nov 09, 2024

Immunocore repays Pharmakon loan, ends agreement - Investing.com India

Nov 09, 2024

Nov 08, 2024

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Barchart

Nov 08, 2024

Nov 06, 2024

Immunocore Holdings earnings beat by $0.50, revenue topped estimates - Investing.com India

Nov 06, 2024

Oct 24, 2024

Immunocore shares maintain buy rating on HIV treatment potential - Investing.com

Oct 24, 2024

Oct 09, 2024

Immunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ... - Yahoo Finance

Oct 09, 2024

Oct 03, 2024

Immunocore stock hits 52-week low at $29.72 amid market challenges - Investing.com

Oct 03, 2024

Sep 30, 2024

Immunocore's SWOT analysis: biotech stock poised for growth amid clinical trials - Investing.com UK

Sep 30, 2024

Sep 24, 2024

Financial Fitness Check: Examining Immunocore Holdings plc ADR (IMCR)’s Key Ratios - The Dwinnex

Sep 24, 2024

Sep 23, 2024

Immunocore stock hits 52-week low at $32.07 amid market challenges - Investing.com

Sep 23, 2024

Sep 16, 2024

TD Cowen maintains Buy rating on Immunocore shares on ovarian cancer drug data - Investing.com India

Sep 16, 2024

Sep 16, 2024

Quarterly Metrics: Quick and Current Ratios for Immunocore Holdings plc ADR (IMCR) - The Dwinnex

Sep 16, 2024

Sep 16, 2024

Immunocore Holdings plc ADR (IMCR) is looking forward to a strong quarter - SETE News

Sep 16, 2024

Sep 11, 2024

Immunocore stock hits 52-week low at $32.84 amid market challenges - Investing.com

Sep 11, 2024

Sep 11, 2024

Ratios Revealed: Decoding Immunocore Holdings plc ADR (IMCR)’s Financial Health - The Dwinnex

Sep 11, 2024

Sep 11, 2024

Have you been able to find a good deal on Immunocore Holdings plc ADR’s shares? - US Post News

Sep 11, 2024

Sep 04, 2024

Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds - Yahoo Finance UK

Sep 04, 2024